1 udy was to determine the pharmacokinetics of anti-asthmatic activity of inhaled heparin in EIA and co

2 20 months) rats with montelukast, a marketed anti-asthmatic drug antagonizing leukotriene receptors,

3             This study aimed to evaluate the anti-asthmatic effects of MSCs primed with Liproxstatin-

4 iene-1 receptors, are the first new class of anti-asthmatics introduced in over 30 years.

5 ompared to the non-AIT group, receiving only anti-asthmatic medication.

6 nt mucous plugs not achieved by conventional anti-asthmatic therapies such as inhaled corticosteroids